NCT05812677 2023-04-14
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
Shanghai Yunying Medical Technology
Fifth Affiliated Hospital, Sun Yat-Sen University
Shanghai Fengxian District Central Hospital
Shanghai OriginCell Therapeutics Co., Ltd.
University of Nevada, Reno
The University of The West Indies
Catholic University of the Sacred Heart
Massachusetts General Hospital